Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |